Tuina may reduce fatigue severity in chronic fatigue syndrome, but evidence is pending from an ongoing randomized controlled trial.
This is a study protocol for a multicenter, parallel-group randomized controlled trial evaluating Tuina (traditional Chinese manual therapy) for chronic fatigue syndrome (CFS). The trial will enroll 166 participants with CFS, randomized 1:1 to Tuina (twice weekly for 8 weeks) or standardized usual care (health education and symptom management). The primary outcome is change in Fatigue Scale-14 (FS-14) score from baseline to week 8, with secondary outcomes including quality of life, sleep, pain, anxiety, depression, gastrointestinal symptoms, bowel function, and handgrip strength. Exploratory mechanistic outcomes include plasma tryptophan-pathway metabolites, gut microbiota profiling, resting-state fMRI, and magnetic resonance spectroscopy.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Tuina may reduce fatigue severity in chronic fatigue syndrome, but evidence is pending from an ongoing randomized controlled trial. The current body of evidence comprises 1 study, including 1 randomized controlled trial. EvidenceHub rates the overall confidence at 44/100 (low).
The Claim
Tuina may reduce fatigue severity in chronic fatigue syndrome, but evidence is pending from an ongoing randomized controlled trial.
This conclusion is most relevant to: Adults with chronic fatigue syndrome (CFS) (n=166).
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Tuina for chronic fatigue syndrome: study protocol for a randomized controlled trial integrating tryptophan metabolism, gut microbiota, and brain network alterations. (Frontiers in neuroscience, 2026) —
How It Works
The proposed biological pathway:
- ▸Tuina stimulates somatosensory, autonomic, and stress-related pathways
- ▸Modulates gastrointestinal function and gut microbiota composition
- ▸Alters tryptophan metabolism and downstream metabolites (e.g., kynurenine, serotonin)
- ▸Influences brain network activity and connectivity via gut-brain axis, potentially reducing fatigue
Who Might Benefit
Evidence fit by population:
- ▸Adults with chronic fatigue syndrome (CFS) (n=166)
Recommended Dose
Tuina twice weekly for 8 weeks
Limitations & Caveats
Important context when interpreting this evidence:
- ▸This is a study protocol; no clinical results are available yet, so efficacy cannot be confirmed.
- ▸The control group receives usual care (not sham Tuina), so placebo effects cannot be fully controlled.
- ▸Exploratory mechanistic outcomes may be underpowered to detect significant changes in gut-brain measures.
Frequently Asked Questions
What is Tuina and how is it applied in this trial?▼
Tuina is a traditional Chinese manual therapy involving massage and manipulation of soft tissues. In this trial, it is administered twice weekly for 8 weeks to participants with chronic fatigue syndrome.
What is the primary outcome of this trial?▼
The primary outcome is the change in Fatigue Scale-14 (FS-14) score from baseline to week 8, measuring fatigue severity.
How many participants are enrolled and how are they allocated?▼
The trial plans to enroll 166 participants with CFS, allocated in a 1:1 ratio to either the Tuina group or a standardized usual care group.
What mechanistic measures are being explored?▼
The trial explores plasma tryptophan-pathway metabolites, gut microbiota profiling, resting-state functional magnetic resonance imaging (fMRI), and magnetic resonance spectroscopy to understand gut-brain interactions.
References
- 1.Jin M, Fang S, Xu S, Cao B, Li J, Ren J, Wang S, Kong L, Zhu Q, Fang M. “Tuina for chronic fatigue syndrome: study protocol for a randomized controlled trial integrating tryptophan metabolism, gut microbiota, and brain network alterations..” Frontiers in neuroscience, 2026. PMID: 42656510 DOI: 10.3389/fnins.2026.1859226